Applied DNA Sciences (APDN) Misses Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. AZN
5. FICO
6. GMAB
7. QQQ
8. SPCX
9. APO
10. SMMT

Go back to Applied DNA Sciences (APDN) Misses Q2 EPS by 2c

Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

May 14, 2020 4:05 PM EDT

Company to Hold Conference Call and Webcast Today, Thursday, May 14, 2020, at 4:30 p.m. EDT

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences Inc. (NASDAQ: APDN) (Applied DNA or the Company) a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, today announced consolidated financial results for the fiscal second quarter and the six months ended March 31, 2020.

Continued execution on our strategic priorities in our second fiscal... More